Login to Your Account



Start-Up RedX Forming $62M Cancer Research Center

By Nuala Moran


Wednesday, June 29, 2011
LONDON – A UK start-up has unveiled plans to form a £39 million (US$62 million) cancer research center after reaching proof of principal for a technology, originally developed at AstraZeneca plc, which makes it possible to generate patentable analogues of existing drugs. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription